KK

Klaus G. Klumpp

RI Riboscience: 10 patents #1 of 6Top 20%
NT Novira Therapeutics: 2 patents #11 of 13Top 85%
Johnson & Johnson: 2 patents #3,442 of 7,810Top 45%
RA Roche Palo Alto: 1 patents #205 of 347Top 60%
Overall (All Time): #369,466 of 4,157,543Top 9%
13
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12029744 Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors Ronald Charles Hawley 2024-07-09
11351186 4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication Mark Smith 2022-06-07
11129834 Combinations and methods comprising a capsid assembly inhibitor George D. Hartman, Osvaldo A. Flores, Man Iu Lam, Jan Martin Berke 2021-09-28
10953030 4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication Mark Smith 2021-03-23
10682369 4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication Mark Smith 2020-06-16
10441589 Combinations and methods comprising a capsid assembly inhibitor George D. Hartman, Osvaldo A. Flores, Man Iu Lam, Jan Martin Berke 2019-10-15
10358458 4′-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication Mark Smith 2019-07-23
10092649 4′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication Mark Smith 2018-10-09
9895442 4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication Mark Smith 2018-02-20
9694028 4′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication Mark Smith 2017-07-04
9370569 4′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication Mark Smith 2016-06-21
9249176 4′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication Mark Smith 2016-02-02
7608599 Antiviral phosphoramidates Joseph Armstrong Martin, Christopher McGuigan, David Bernard Smith 2009-10-27